PROPIVERINE


Synonyms	Detrunorm Detrunorm xl Mictonetten Mictonorm NSC-172140 Propiverine Propiverine hydrochloride
Status
Molecule Category	Free-form
ATC	G04BD06
UNII	468GE2241L
EPA CompTox	DTXSID5048265


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	QPCVHQBVMYCJOM-UHFFFAOYSA-N
Smiles	CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1
InChI	InChI=1S/C23H29NO3/c1-3-18-26-23(19-10-6-4-7-11-19,20-12-8-5-9-13-20)22(25)27-21-14-16-24(2)17-15-21/h4-13,21H,3,14-18H2,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C23H29NO3
Molecular Weight	367.49
AlogP	3.99
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	7.0
Polar Surface Area	38.77
Molecular species	BASE
Aromatic Rings	2.0
Heavy Atoms	27.0

Related Entries

Cross References

Resources	Reference
ChEBI	8493
ChEMBL	CHEMBL1078261
DrugBank	DB12278
DrugCentral	2300
FDA SRS	468GE2241L
Human Metabolome Database	HMDB0041999
KEGG	C07852
PubChem	4942
SureChEMBL	SCHEMBL94695
ZINC	ZINC000001530934

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).